Concordantly with a previous report [47-49], we speculate that further investigation of the molecular interaction between NF-κ B and PPAR-α in liver may help to develop therapeutic approaches for the treatment of hepatic diseases associated with diabetes mellitus. Here, PPARA is linked to liver disorder.